Snapshot of the companys recent financial performance In the first nine months of 2023, the AstraZenecas total revenue was $33.787 billion, up 5%, with a 15% increase excluding COVID-19 medicines
However, from clinical studies alone, it is difficult to know how much of the benefit is due to direct effects in the joint and how much may be explained by weight loss or broader metabolic changes. That is why we wanted to address a basic mechanistic question first: whether GLP-1 is actually present in the joint environment
After screening 258 human GPCRs, we identified GPR55 as a potential target of curcumin, based on a significant activation of the reporter construct by curcumin
About 1.4 million UK people receive GLP-1Ra drugs monthly, most through private, especially online providers
W.et al (2024)
And if you're just starting a GLP-1 medication now, our First Week on GLP-1 guide walks you through day by day